Bayard R. Huck

1.3k citations

28 papers · 995 indexed · h-index 16

Co-authors: Samuel H. Gellman Klaus Urbahns Lisa Kötzner John D. Fisk Rienk Offringa Ronald T. Raines Ulrich Arnold Douglas R. Powell
Topics: Chemical Synthesis and Analysis (10 papers)Click Chemistry and Applications (6 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
Cited by: Microbiology Organic Chemistry Molecular Biology
Journals: Journal of the American Chemical Society Angewandte Chemie International Edition Nature Reviews Drug Discovery
Partner nations: United States Germany Italy

In The Last Decade

Bayard R. Huck

28 papers receiving 970 citations

Peers

Countries citing papers authored by Bayard R. Huck

Since Specialization

Citations

This map shows the geographic impact of Bayard R. Huck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bayard R. Huck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bayard R. Huck more than expected).

Fields of papers citing papers by Bayard R. Huck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bayard R. Huck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bayard R. Huck. The network helps show where Bayard R. Huck may publish in the future.

Co-authorship network of co-authors of Bayard R. Huck

This figure shows the co-authorship network connecting the top 25 collaborators of Bayard R. Huck. A scholar is included among the top collaborators of Bayard R. Huck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bayard R. Huck. Bayard R. Huck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo 2024 ·Molecular Cancer Therapeutics ·Kai Schiemann,(unknown),(unknown),Kalyan C. Nallaparaju,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Carsten Boesler,(unknown),Marc Lecomte,(unknown),(unknown),Stéphan Schann,Bayard R. Huck,Jacques Moisan,Rinat Zaynagetdinov	6
2	Rules were made to be broken 2023 ·Nature Reviews Chemistry ·Ingo V. Hartung,Bayard R. Huck,Alejandro Crespo	45
3	The expanding role for small molecules in immuno-oncology 2022 ·Nature Reviews Drug Discovery ·Rienk Offringa,Lisa Kötzner,Bayard R. Huck,Klaus Urbahns	92
4	Small molecules—Giant leaps for immuno-oncology 2020 ·Progress in medicinal chemistry ·Lisa Kötzner,Bayard R. Huck,Sakshi Garg,Klaus Urbahns	3
5	Recent progress towards clinically relevant ATP-competitive Akt inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·Bayard R. Huck,Igor Mochalkin	29
6	Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies 2017 ·Angewandte Chemie International Edition ·Bayard R. Huck,Lisa Kötzner,Klaus Urbahns	111
7	Kleine Moleküle, ganz groß: niedermolekulare immunonkologische Kombinationstherapien 2017 ·Angewandte Chemie ·Bayard R. Huck,Lisa Kötzner,Klaus Urbahns	1
8	A first in human, dose escalation trial of MSC2363318A – a dual p70S6K/Akt inhibitor, for patients with advanced malignancies 2015 ·Annals of Oncology ·Apostolia M. Tsimberidou,Claire F. Verschraegen,Gregory M. Heestand,(unknown),(unknown),Bayard R. Huck,Amy Weise,Razelle Kurzrock	5
9	SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Srinivasa Karra,Yufang Xiao,Xiaoling Chen,Lesley Liu‐Bujalski,Bayard R. Huck,Amanda Sutton,Andreas Goutopoulos,Ben Askew,Kristopher Josephson,Xuliang Jiang,Adam Shutes,(unknown),(unknown),(unknown),Rong Dong,Mohanraj Dhanabal,Hui Tian,Zhenxiong Wang,(unknown),(unknown)	15
10	Protein prosthesis: β‐peptides as reverse‐turn surrogates 2012 ·Protein Science ·Ulrich Arnold,Bayard R. Huck,Samuel H. Gellman,Ronald T. Raines	18
11	The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Bayard R. Huck,Luis Llamas,(unknown),(unknown),Jianping Song,William F. Hodnick,(unknown),Alain Stricker‐Krongrad,John Harrington,Kurt R. Brunden,Youssef L. Bennani	12
12	The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist 2006 ·Bioorganic & Medicinal Chemistry Letters ·Bayard R. Huck,Luis Llamas,(unknown),(unknown),Jianping Song,William F. Hodnick,(unknown),Alain Stricker‐Krongrad,John Harrington,Kurt R. Brunden,Youssef L. Bennani	22
13	Synthesis of 2,2-Disubstituted Pyrrolidine-4-carboxylic Acid Derivatives and Their Incorporation into β-Peptide Oligomers 2005 ·The Journal of Organic Chemistry ·Bayard R. Huck,Samuel H. Gellman	28
14	The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·L. Nathan Tumey,David Bom,Bayard R. Huck,(unknown),Jianmin Wang,Daniel P. Silver,Kurt R. Brunden,Sherry Boozer,Stephen E. Rundlett,Bruce A. Sherf,Steven M. Murphy,(unknown),(unknown),(unknown),John Harrington,Youssef L. Bennani	70
15	The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·L. Nathan Tumey,Bayard R. Huck,(unknown),Jianmin Wang,Daniel P. Silver,Kurt R. Brunden,Sherry Boozer,Stephen E. Rundlett,Bruce A. Sherf,Steven M. Murphy,(unknown),(unknown),(unknown),John Harrington,Youssef L. Bennani	17
16	Design of Non-Cysteine-Containing Antimicrobial β-Hairpins: Structure−Activity Relationship Studies with Linear Protegrin-1 Analogues 2002 ·Biochemistry ·Jonathan R. Lai,Bayard R. Huck,Bernard Weisblum,Samuel H. Gellman	71
17	Protein Prosthesis: A Semisynthetic Enzyme with a β-Peptide Reverse Turn 2002 ·Journal of the American Chemical Society ·Ulrich Arnold,(unknown),Bradley L. Nilsson,Bayard R. Huck,Samuel H. Gellman,Ronald T. Raines	105
18	Promotion of Sheet Formation in α-Peptide Strands by a β-Peptide Reverse Turn 2000 ·Organic Letters ·Bayard R. Huck,John D. Fisk,Samuel H. Gellman	60
19	ChemInform Abstract: Stereochemical Control of Hairpin Formation in β‐Peptides Containing Dinipecotic Acid Reverse Turn Segments. 2000 ·ChemInform ·Yong Jun Chung,Bayard R. Huck,Laurie A. Christianson,Heather E. Stanger,(unknown),Douglas R. Powell,(unknown)	12
20	Non-Hydrogen-Bonded Secondary Structure in β-Peptides: Evidence from Circular Dichroism of (S)-Pyrrolidine-3- carboxylic Acid Oligomers and (S)-Nipecotic Acid Oligomers 1999 ·Organic Letters ·Bayard R. Huck,Joseph M. Langenhan,Samuel H. Gellman	42

About Bayard R. Huck

Bayard R. Huck is a scholar working on Physiology, Molecular Biology and Organic Chemistry, having authored 28 papers that have together received 995 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (10 papers), Click Chemistry and Applications (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Microbiology (108 citations), Organic Chemistry (379 citations) and Molecular Biology (737 citations). Bayard R. Huck has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Samuel H. Gellman, Klaus Urbahns, Lisa Kötzner, John D. Fisk, Rienk Offringa, Ronald T. Raines, Ulrich Arnold, Douglas R. Powell, Laurie A. Christianson and Heather E. Stanger. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact